Re: Letter written in reaction to “Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database”, by Pottegard et al. – The authors (Asomaning et al.) respond.

HOME
>
論文・技術情報
>
Re: Letter written in reaction to “Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database”, by Pottegard et al. – The authors (Asomaning et al.) respond.

アブストラクト
ジャーナル名	International journal of clinical practice
Pubmed追加日	2016/7/29
投稿者	Asomaning, K; Abramsky, S; Liu, Q; Zhou, X; Sobel, R E; Watt, S
組織名	Department of Epidemiology, Pfizer Inc, New York, NY, USA.;kofi.asomaning@pfizer.com.;Department of Medical Affairs, Pfizer Inc, New York, NY, USA.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/27466016/